Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Encision ( (ECIA) ) is now available.
On January 29, 2026, Encision Inc. announced that its board had approved the voluntary deregistration of its common stock with the Securities and Exchange Commission by filing a Form 15 under Section 12(g) of the Exchange Act. The move, expected to become fully effective 90 days after filing, will suspend the company’s SEC reporting obligations, including annual, quarterly, and current reports, and is aimed at reducing compliance costs and management burden relative to Encision’s size and market capitalization, while the company intends to continue publishing unaudited quarterly and annual financial results and expects its shares to keep trading on the over-the-counter market, albeit without assurance of continued liquidity.
The most recent analyst rating on (ECIA) stock is a Hold with a $0.14 price target. To see the full list of analyst forecasts on Encision stock, see the ECIA Stock Forecast page.
Spark’s Take on ECIA Stock
According to Spark, TipRanks’ AI Analyst, ECIA is a Neutral.
ECIA scores low primarily due to weak financial performance—ongoing losses, negative TTM cash flow, and especially the TTM balance-sheet red flags (zero equity/negative assets). Technicals also weigh on the score with a clear downtrend and negative MACD, despite an RSI near oversold. Valuation provides limited support because the negative P/E reflects unprofitable operations and there is no dividend yield.
To see Spark’s full report on ECIA stock, click here.
More about Encision
Encision Inc., based in Boulder, Colorado, is a medical device company that designs and markets high-performance surgical instruments incorporating its patented Active Electrode Monitoring (AEM) technology, which is designed to prevent dangerous stray or radiant energy burns during minimally invasive surgical procedures. Its portfolio targets hospitals and providers seeking improved patient safety, surgical performance, and value across a broad range of minimally invasive surgeries.
Average Trading Volume: 9,375
Technical Sentiment Signal: Sell
Current Market Cap: $3.19M
For detailed information about ECIA stock, go to TipRanks’ Stock Analysis page.